These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
974 related items for PubMed ID: 6330206
1. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells. Razin E, Romeo LC, Krilis S, Liu FT, Lewis RA, Corey EJ, Austen KF. J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206 [Abstract] [Full Text] [Related]
2. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. Mencia-Huerta JM, Lewis RA, Razin E, Austen KF. J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819 [Abstract] [Full Text] [Related]
3. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells. Mencia-Huerta JM, Razin E, Ringel EW, Corey EJ, Hoover D, Austen KF, Lewis RA. J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233 [Abstract] [Full Text] [Related]
4. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. Robin JL, Seldin DC, Austen KF, Lewis RA. J Immunol; 1985 Oct; 135(4):2719-26. PubMed ID: 3161947 [Abstract] [Full Text] [Related]
5. Activation of the 5-lipoxygenase pathway in E-mast cells by peanut agglutinin. Razin E. J Immunol; 1985 Feb; 134(2):1142-5. PubMed ID: 3917471 [Abstract] [Full Text] [Related]
6. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2. Levi-Schaffer F, Dayton ET, Austen KF, Hein A, Caulfield JP, Gravallese PM, Liu FT, Stevens RL. J Immunol; 1987 Nov 15; 139(10):3431-41. PubMed ID: 2445814 [Abstract] [Full Text] [Related]
7. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone. Benhamou M, Ninio E, Salem P, Hieblot C, Bessou G, Pitton C, Liu FT, Mencia-Huerta JM. J Immunol; 1986 Feb 15; 136(4):1385-92. PubMed ID: 2935578 [Abstract] [Full Text] [Related]
8. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. Katz HR, Raizman MB, Gartner CS, Scott HC, Benson AC, Austen KF. J Immunol; 1992 Feb 01; 148(3):868-71. PubMed ID: 1309842 [Abstract] [Full Text] [Related]
9. BW755C inhibits the 5-lipoxygenase in E-mast cells without affecting degranulation. Shoam H, Razin E. Biochim Biophys Acta; 1985 Oct 23; 837(1):1-5. PubMed ID: 2413896 [Abstract] [Full Text] [Related]
10. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. Williams JD, Lee TH, Lewis RA, Austen F. J Immunol; 1985 Apr 23; 134(4):2624-30. PubMed ID: 2982947 [Abstract] [Full Text] [Related]
11. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages. Laviolette M, Carreau M, Coulombe R, Cloutier D, Dupont P, Rioux J, Braquet P, Borgeat P. J Immunol; 1988 Sep 15; 141(6):2104-9. PubMed ID: 2844895 [Abstract] [Full Text] [Related]
12. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. Razin E, Mencia-Huerta JM, Stevens RL, Lewis RA, Liu FT, Corey E, Austen KF. J Exp Med; 1983 Jan 01; 157(1):189-201. PubMed ID: 6184439 [Abstract] [Full Text] [Related]
13. Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration. Marquardt DL, Wasserman SI. J Immunol; 1983 Aug 01; 131(2):934-9. PubMed ID: 6306110 [Abstract] [Full Text] [Related]
14. Effects of a specific inhibitor of the 5-lipoxygenase pathway on mediator release from human basophils and mast cells. Warner JA, Lichtenstein LM, MacGlashan DW. J Pharmacol Exp Ther; 1988 Oct 01; 247(1):218-22. PubMed ID: 3139865 [Abstract] [Full Text] [Related]
15. Granule-associated serine neutral proteases of the mouse bone marrow-derived mast cell that degrade fibronectin: their increase after sodium butyrate treatment of the cells. DuBuske L, Austen KF, Czop J, Stevens RL. J Immunol; 1984 Sep 01; 133(3):1535-41. PubMed ID: 6205085 [Abstract] [Full Text] [Related]
16. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF. J Clin Invest; 1984 Dec 01; 74(6):1922-33. PubMed ID: 6096400 [Abstract] [Full Text] [Related]
18. The pharmacologic modulation of the release of arachidonic acid metabolites from purified human lung mast cells. Peters SP, MacGlashan DW, Schleimer RP, Hayes EC, Adkinson NF, Lichtenstein LM. Am Rev Respir Dis; 1985 Aug 01; 132(2):367-73. PubMed ID: 3927806 [Abstract] [Full Text] [Related]
19. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway. Liles WC, Meier KE, Henderson WR. J Immunol; 1987 May 15; 138(10):3396-402. PubMed ID: 3033073 [Abstract] [Full Text] [Related]